Persistent Anestrus and Anovulation

Persistent anestrus and anovulation are reproductive disorders characterized by the absence of estrous cycles (anestrus) or the failure to ovulate despite apparent estrous behavior (anovulation). In the female dog and cat, these conditions represent a disruption of the normal hypothalamic-pituitary-ovarian axis, leading to prolonged intervals between estrous cycles or the absence of corpora lutea formation. Persistent anestrus is defined as the absence of estrus for more than 12 months in the bitch (normal inter-estrous interval is 4-12 months) and more than 6 months in the queen (normal is 2-3 weeks during breeding season). Anovulation is characterized by the presence of proestrus and estrus signs (vulvar swelling, serosanguineous discharge, behavioral receptivity) but failure to ovulate, as confirmed by persistently low serum progesterone concentrations (<2 ng/mL) and lack of luteal tissue on ultrasonography. These conditions may be primary (congenital) or secondary (acquired) and can result in infertility, economic loss in breeding programs, and potential health risks such as cystic endometrial hyperplasia or pyometra if hormonal imbalances persist. The pathophysiology involves complex interactions between gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and ovarian steroids, with disruptions at any level leading to clinical manifestations.

The etiology of persistent anestrus and anovulation is multifactorial. Primary causes include congenital abnormalities such as ovarian dysgenesis, gonadal hypoplasia, or chromosomal aberrations (e.g., XX sex reversal). Secondary causes are more common and include: (1) Iatrogenic factors: prolonged administration of progestins (e.g., megestrol acetate, medroxyprogesterone acetate) or androgens, which suppress GnRH and gonadotropin secretion; (2) Endocrine disorders: hypothyroidism, hyperadrenocorticism, diabetes mellitus, and growth hormone excess can disrupt the reproductive axis; (3) Ovarian pathology: ovarian cysts (follicular, luteal), ovarian neoplasia (granulosa cell tumors, adenocarcinomas), and ovarian remnant syndrome; (4) Nutritional and metabolic factors: obesity, malnutrition, and cachexia alter leptin and insulin signaling, affecting GnRH pulsatility; (5) Stress and environmental factors: overcrowding, transportation, changes in photoperiod (especially in cats), and chronic pain; (6) Infectious and inflammatory conditions: oophoritis, endometritis, or systemic infections; (7) Age-related changes: advanced age leading to ovarian senescence; (8) Genetic predisposition: certain breeds (e.g., Basenji, Norwegian Elkhound) have a higher incidence of prolonged anestrus. Anovulation specifically may result from inadequate LH surge due to insufficient estrogen priming, luteinized unruptured follicles (LUF), or premature ovulation of immature oocytes. In cats, anovulation is often due to lack of copulation-induced LH surge, as cats are induced ovulators.

Persistent anestrus and anovulation are significant causes of infertility in both dogs and cats. In dogs, the incidence of prolonged anestrus (>12 months) is estimated at 5-10% of intact bitches presented for breeding management. Certain breeds, such as the Basenji, Norwegian Elkhound, and German Shepherd, have a higher prevalence of prolonged anestrus, suggesting a genetic component. Anovulation is less common but may occur in 2-5% of estrous cycles, particularly in young or aged bitches. In cats, persistent anestrus is common in indoor cats housed under constant artificial light, as they are seasonally polyestrous and require adequate photoperiod (12-14 hours of light) to cycle. Anovulation in queens is frequently observed when mating is not allowed or when the queen is bred by a vasectomized male, leading to pseudopregnancy. Age is a risk factor: young bitches may have delayed puberty (first estrus >24 months), and aged bitches may experience prolonged anestrus due to ovarian senescence. Parity and breeding status also influence risk; nulliparous bitches and those with irregular cycles are more prone. Environmental stressors, such as kenneling, travel, and competition, can exacerbate the condition. In breeding colonies, the economic impact is substantial due to missed breeding opportunities and increased veterinary costs.

The pathophysiology of persistent anestrus and anovulation involves disruption of the hypothalamic-pituitary-ovarian (HPO) axis. In persistent anestrus, there is a failure of the hypothalamus to secrete GnRH in a pulsatile manner, leading to reduced FSH and LH secretion from the anterior pituitary. This results in ovarian follicular arrest and low estrogen production, preventing the positive feedback that triggers the LH surge. Causes include chronic stress (via cortisol and endogenous opioids), hypothyroidism (reduced metabolic rate and altered steroid feedback), and iatrogenic suppression by exogenous progestins, which inhibit GnRH and gonadotropin release. In anovulation, follicular development may occur normally, but the LH surge is absent or insufficient. This can be due to inadequate estrogen production from the dominant follicle, failure of the positive feedback mechanism, or premature luteinization of the follicle (LUF syndrome). In cats, anovulation is primarily due to the absence of copulation-induced LH surge; without vaginal-cervical stimulation, the preovulatory LH peak does not occur, and follicles may undergo atresia or become luteinized without ovulation. Ovarian cysts, such as follicular cysts, can produce estrogen persistently, leading to prolonged estrus but no ovulation. Neoplastic conditions, like granulosa cell tumors, may secrete steroids or inhibin, disrupting the HPO axis. The end result is a lack of corpora lutea and progesterone production, leading to infertility and potential endometrial hyperplasia due to unopposed estrogen.

Predisposing factors for persistent anestrus and anovulation include intrinsic and extrinsic elements. Intrinsic factors: (1) Breed: Basenji, Norwegian Elkhound, and German Shepherd have genetic predispositions to prolonged anestrus; (2) Age: young bitches (<2 years) may have delayed puberty, while aged bitches (>8 years) may experience ovarian senescence; (3) Nulliparity: bitches that have never whelped are at higher risk; (4) Genetic anomalies: chromosomal abnormalities (e.g., XX sex reversal) and ovarian dysgenesis; (5) Endocrine disorders: hypothyroidism, hyperadrenocorticism, diabetes mellitus, and growth hormone excess; (6) Obesity: adipose tissue produces leptin and estrogen, disrupting the HPO axis; (7) Ovarian pathology: cysts, neoplasia, and ovarian remnants. Extrinsic factors: (1) Iatrogenic: administration of progestins (e.g., megestrol acetate for estrus suppression) or anabolic steroids; (2) Environmental stress: overcrowding, transportation, changes in routine, and chronic pain; (3) Photoperiod: in cats, insufficient light exposure (<12 hours/day) suppresses cyclicity; (4) Nutritional deficiencies: inadequate protein, vitamins, or minerals; (5) Poor breeding management: improper timing of mating, lack of copulation in cats; (6) Infectious agents: brucellosis, herpesvirus, or other systemic infections that cause oophoritis or endometritis.

Clinical signs of persistent anestrus include the absence of estrous cycles for an extended period. In bitches, there is no vulvar swelling, serosanguineous discharge, or behavioral changes (e.g., tail flagging, increased urination) for more than 12 months. In queens, there is no estrus behavior (vocalization, rolling, lordosis) for more than 6 months. Anovulation is characterized by the presence of proestrus and estrus signs, but failure to ovulate. In bitches, estrus may be prolonged (up to 21 days) with persistent vulvar swelling and discharge, but serum progesterone remains <2 ng/mL. In queens, estrus may be prolonged (up to 10 days) if mating does not occur, but ovulation does not occur without copulation. Other signs may include: (1) Behavioral changes: increased aggression or lethargy; (2) Physical examination: normal external genitalia, but palpation may reveal small, inactive ovaries; (3) Vaginal cytology: in anestrus, predominantly parabasal and intermediate cells; in anovulatory estrus, high percentage of superficial cells (cornified) but no shift to intermediate cells post-ovulation; (4) Ultrasonography: ovaries may show small follicles (<2 mm) in anestrus, or large follicles (>5 mm) in anovulatory estrus, but no corpora lutea; (5) Systemic signs: if underlying endocrine disease (e.g., hypothyroidism), may see alopecia, weight gain, and lethargy.

Differential diagnoses for persistent anestrus and anovulation include: (1) Silent estrus: a normal estrous cycle with ovulation but no external signs; diagnosed by serial progesterone measurements and ultrasonography showing corpora lutea; (2) Subestrus: a weak estrus with minimal signs but ovulation occurs; (3) Split estrus: two estrous periods separated by a short anestrus, often due to inadequate LH surge; (4) Ovarian remnant syndrome: ovarian tissue remains after ovariohysterectomy, causing estrus signs; diagnosed by hormonal assays (elevated estradiol) and ultrasonography; (5) Cystic ovarian disease: follicular cysts produce estrogen, causing prolonged estrus; luteal cysts produce progesterone, causing persistent diestrus; (6) Ovarian neoplasia: granulosa cell tumors may secrete estrogen or progesterone, leading to various signs; (7) Hypothyroidism: causes prolonged anestrus; diagnosed by low T4 and high TSH; (8) Hyperadrenocorticism: causes anestrus due to cortisol excess; (9) Diabetes mellitus: may disrupt cyclicity; (10) Pregnancy or pseudopregnancy: may mimic anestrus if not detected; (11) Pyometra: may cause systemic signs and anestrus; (12) Foreign body or vaginal stricture: may prevent mating but not affect cyclicity.

The diagnostic algorithm for persistent anestrus and anovulation should proceed systematically: (1) History and physical examination: assess signalment, breeding history, previous estrus cycles, and any medication use; (2) Vaginal cytology: collect samples every 2-3 days to assess cyclicity; in anestrus, parabasal and intermediate cells; in estrus, >90% superficial cells; (3) Serum progesterone measurement: perform twice weekly during suspected estrus; ovulation is confirmed when progesterone >2 ng/mL; in anovulation, progesterone remains <2 ng/mL; (4) Serum estradiol measurement: elevated during proestrus/estrus; in persistent anestrus, low (<20 pg/mL); (5) LH assay: may be used to detect the LH surge, but is often impractical due to short half-life; (6) Ultrasonography: assess ovarian structures; in anestrus, small inactive ovaries; in anovulatory estrus, large follicles but no corpora lutea; (7) Thyroid function tests: T4, free T4, TSH to rule out hypothyroidism; (8) Adrenal function tests: ACTH stimulation test to rule out hyperadrenocorticism; (9) Karyotyping: if congenital abnormalities suspected; (10) Laparoscopy or exploratory laparotomy: to visualize ovaries and confirm ovarian remnant or neoplasia; (11) Vaginal or uterine culture: if infection suspected; (12) Biopsy: of ovarian masses or remnant tissue for histopathology.

Laboratory findings in persistent anestrus and anovulation include: (1) Serum progesterone: <2 ng/mL in anovulation; <1 ng/mL in persistent anestrus; (2) Serum estradiol: low (<20 pg/mL) in anestrus; elevated (>50 pg/mL) during estrus but may be normal in anovulation; (3) LH: may be elevated in ovarian failure due to lack of negative feedback; (4) FSH: elevated in primary ovarian failure; (5) Thyroid panel: low T4 (<1.0 μg/dL) and high TSH (>0.6 ng/mL) in hypothyroidism; (6) Cortisol: elevated in hyperadrenocorticism; (7) Complete blood count: may show leukocytosis if infection; (8) Biochemistry: may show elevated liver enzymes or hyperglycemia in diabetes; (9) Vaginal cytology: in anestrus, parabasal and intermediate cells with no superficial cells; in anovulatory estrus, >90% superficial cells but no shift to intermediate cells; (10) Uterine culture: may reveal bacterial growth if endometritis; (11) Histopathology of ovarian biopsy: may show follicular cysts, luteinized follicles, or neoplasia.

Imaging findings are crucial for diagnosis. Abdominal ultrasonography: In persistent anestrus, ovaries are small (1-2 cm) with no follicles >2 mm; uterine horns are thin and uniform. In anovulatory estrus, ovaries may contain multiple follicles >5 mm, but no corpora lutea; uterine wall may be thickened due to estrogen stimulation. In cats, follicles may be >3 mm. Ultrasonography can also detect ovarian cysts (anechoic structures >10 mm), ovarian masses (solid or complex), and ovarian remnants (small tissue near the kidney). Radiography: Not typically useful for ovarian evaluation, but may detect mineralized ovarian masses (e.g., granulosa cell tumors) or fetal skeletons if pregnancy is suspected. CT and MRI: Provide detailed imaging of the reproductive tract, useful for detecting ovarian remnants or neoplasia, but are rarely necessary. Vaginoscopy: Can assess vaginal mucosa and detect strictures or foreign bodies, but does not directly evaluate ovarian function.

Vaginal cytology is a cornerstone of reproductive assessment. In persistent anestrus, smears show predominantly parabasal and intermediate cells, with few superficial cells and no neutrophils. In anovulatory estrus, smears show >90% superficial cells (cornified) for an extended period, but no shift to intermediate cells, indicating lack of ovulation. Histopathology of ovarian tissue is essential for definitive diagnosis of ovarian cysts, neoplasia, or remnant tissue. Follicular cysts are lined by granulosa cells and may be multiple; luteal cysts have a luteinized theca interna. Granulosa cell tumors show characteristic Call-Exner bodies and may be benign or malignant. Ovarian remnant tissue shows normal ovarian stroma with follicles or corpora lutea. Endometrial biopsy may reveal cystic endometrial hyperplasia if estrogen stimulation is prolonged. Special stains, such as immunohistochemistry for inhibin, can help diagnose granulosa cell tumors.

Treatment of persistent anestrus and anovulation depends on the underlying cause and the goal (breeding vs. pet). For breeding animals, the aim is to induce fertile estrus and ovulation. Protocols include: (1) For persistent anestrus: (a) Administer GnRH (e.g., gonadorelin 2-5 μg/kg IM) or hCG (e.g., 500-1000 IU IM) to stimulate follicular development and ovulation; (b) Use FSH (e.g., porcine FSH 20-40 IU IM daily for 3-5 days) to induce follicular growth; (c) For hypothyroidism, supplement levothyroxine (0.02-0.04 mg/kg PO q12h) until T4 normalizes; (d) For obesity, implement weight loss program; (e) For stress, reduce environmental stressors. (2) For anovulation: (a) Administer hCG (500-1000 IU IM) or GnRH (2-5 μg/kg IM) at the time of estrus to induce ovulation; (b) In cats, allow natural mating or use a vasectomized male to stimulate LH surge; (c) If LUF syndrome is suspected, use hCG at the time of follicle maturity (follicle >5 mm on ultrasound). (3) For ovarian cysts: (a) Follicular cysts may be treated with GnRH or hCG to induce luteinization, followed by PGF2α (e.g., dinoprost 0.1-0.25 mg/kg SC q12h) to lyse the luteal cyst; (b) Surgical removal (ovariectomy or ovariohysterectomy) if medical therapy fails. (4) For ovarian neoplasia: surgical excision (ovariohysterectomy) is recommended. (5) For ovarian remnant syndrome: surgical removal of remnant tissue. (6) Supportive care: antibiotics if infection, anti-inflammatory drugs if needed. (7) For non-breeding pets, ovariohysterectomy is the treatment of choice to prevent future reproductive issues.

The prognosis for persistent anestrus and anovulation depends on the underlying cause. For simple anovulation due to inadequate LH surge, prognosis is good with appropriate hormonal therapy (hCG or GnRH), with conception rates of 70-80% if bred at the correct time. For persistent anestrus due to hypothyroidism, prognosis is excellent with thyroid hormone replacement, with return to cyclicity within 2-4 months. For ovarian cysts, prognosis is good with medical or surgical treatment, but recurrence is possible. For ovarian neoplasia, prognosis is guarded to poor if malignant, but benign tumors have a good prognosis after surgical removal. For ovarian remnant syndrome, prognosis is good after surgical removal. For congenital abnormalities (e.g., ovarian dysgenesis), prognosis for fertility is poor. Overall, the prognosis for future fertility is good if the underlying cause is treatable and the animal is otherwise healthy. However, if the condition is due to age-related ovarian senescence, fertility is unlikely to be restored.

Follow-up is essential to monitor response to treatment and ensure successful breeding. After induction of estrus, monitor vaginal cytology and serum progesterone every 2-3 days. Ovulation is confirmed when progesterone >2 ng/mL. If ovulation is induced with hCG or GnRH, perform ultrasonography 5-7 days later to confirm corpora lutea. If pregnancy is desired, breed 2-3 days after the LH surge or when progesterone is 4-10 ng/mL. If not pregnant, monitor for return to estrus. For animals with hypothyroidism, recheck T4 levels every 2-4 weeks until stable, then every 6 months. For animals with ovarian cysts, repeat ultrasonography 2-4 weeks after treatment to ensure resolution. For animals that underwent surgery, monitor incision healing and check for signs of infection. For breeding management, keep detailed records of estrous cycles, hormone levels, and breeding dates. If the animal does not conceive after 2-3 cycles, consider further diagnostic workup (e.g., hysteroscopy, genetic testing).

Clinical pearls: (1) Always confirm ovulation with progesterone >2 ng/mL, not just behavioral estrus; (2) In cats, ovulation is induced by copulation; if breeding is not observed, consider using a vasectomized male to stimulate LH surge; (3) For persistent anestrus, rule out hypothyroidism before starting hormonal therapy; (4) Use ultrasonography to monitor follicle size; administer hCG when follicles are 5-7 mm in bitches and 3-4 mm in queens; (5) For ovarian remnant syndrome, perform ultrasonography during estrus to identify remnant tissue; (6) In cases of anovulation, consider LUF syndrome; treat with hCG at the time of follicle maturity. Pitfalls: (1) Do not administer progestins to suppress estrus in breeding animals, as they can cause prolonged anestrus; (2) Avoid using high doses of FSH, which can cause ovarian hyperstimulation and cyst formation; (3) Do not rely solely on vaginal cytology to diagnose ovulation; always measure progesterone; (4) In cats, do not assume anestrus is normal; evaluate photoperiod and consider light therapy; (5) Do not delay surgical treatment for ovarian neoplasia, as it may be malignant; (6) Be cautious with PGF2α in pregnant animals, as it can cause abortion; (7) Always rule out pregnancy before treating with PGF2α or other abortifacients.

Current drug protocols for persistent anestrus and anovulation include: (1) GnRH (gonadorelin): 2-5 μg/kg IM, once, to induce ovulation; may be repeated in 24-48 hours if no response; (2) hCG (human chorionic gonadotropin): 500-1000 IU IM, once, to induce ovulation; (3) FSH (porcine FSH): 20-40 IU IM daily for 3-5 days to induce follicular growth; (4) Levothyroxine: 0.02-0.04 mg/kg PO q12h, adjust based on T4 levels; (5) PGF2α (dinoprost tromethamine): 0.1-0.25 mg/kg SC q12h for 2-5 days to lyse luteal cysts; (6) Cloprostenol: 1-2 μg/kg SC, may be used as an alternative to dinoprost; (7) Cabergoline: 5 μg/kg PO q24h for 5-10 days to reduce prolactin and shorten anestrus; (8) Progesterone (for luteal phase support): 2-4 mg/kg PO q24h or 1-2 mg/kg IM q48h, but use with caution; (9) Antibiotics: if infection is present, use appropriate antibiotics based on culture and sensitivity; (10) Anti-inflammatory drugs: e.g., carprofen 2.2 mg/kg PO q12h, for pain or inflammation; (11) For cats, light therapy: provide 12-14 hours of light per day to stimulate cyclicity.

Evidence-based literature supports the use of GnRH and hCG for ovulation induction in bitches and queens. A study by Kutzler et al. (2009) demonstrated that hCG (500 IU) administered when follicles were >5 mm resulted in ovulation in 80% of bitches. Another study by England et al. (2012) showed that GnRH (2 μg/kg) was effective in inducing ovulation in bitches with anovulatory estrus. For persistent anestrus, a study by Johnston et al. (2001) reported that treatment with FSH (20 IU/kg) for 5 days induced estrus in 70% of bitches with prolonged anestrus. In cats, a study by Goodrowe et al. (1989) found that natural mating was more effective than hCG in inducing ovulation, with a 100% ovulation rate. The use of cabergoline to shorten anestrus has been supported by studies showing a reduction in inter-estrous interval by 2-3 weeks. Consensus guidelines from the American College of Theriogenologists (ACT) and the European Society for Small Animal Reproduction (EVSSAR) recommend a thorough diagnostic workup before initiating hormonal therapy, and emphasize the importance of monitoring progesterone to confirm ovulation. Overall, the evidence supports a good prognosis for fertility when the underlying cause is identified and treated appropriately.